Press releases
Your source for Evernorth news.
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Estimated to save individual Accredo patients around $4,000 per year
Biosimilar price will be more than 80% lower than Stelara list price
Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (48)
Press Release
Express Scripts Comments on FTC’s Reckless Insulin Action
September 20, 2024
Press Release
Express Scripts Sues FTC, Demands Withdrawal of PBM Report
September 17, 2024
Press Release
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
September 05, 2024
Press Release
Evernorth Names Tony Colistra New President of MD Live, Evernorth Workplace Care
September 04, 2024
Press Release
Express Scripts by Evernorth Members Paid Less for Their Share of Prescriptions in 2023 Despite Drug Price Increases
June 19, 2024
Members with employer-sponsored insurance saw about a 1% decrease in their portion out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply